|
US2519863A
(en)
|
1949-05-14 |
1950-08-22 |
Eastman Kodak Co |
Conversion of beta-, gamma-, and delta-tocopherol to alpha-tocopherol by aminoalkylation and reduction
|
|
US4977282A
(en)
*
|
1984-04-17 |
1990-12-11 |
Henkel Corporation |
Production of d-alpha-tocopherol from natural plant sources
|
|
EP0159018A3
(en)
*
|
1984-04-17 |
1986-10-01 |
HENKEL CORPORATION (a Delaware corp.) |
Production of d-alpha-tocopherol from natural plant sources
|
|
US4603142A
(en)
|
1984-06-01 |
1986-07-29 |
Wisconsin Alumni Research Foundation |
Cholesterol lowering method of use
|
|
JPS636186A
(ja)
|
1986-06-23 |
1988-01-12 |
タツタ電線株式会社 |
点滴監視装置
|
|
JPH0788376B2
(ja)
|
1986-09-02 |
1995-09-27 |
エーザイ株式会社 |
光学活性α−トコトリエノ−ルの製造方法
|
|
JP2685785B2
(ja)
|
1988-03-11 |
1997-12-03 |
エーザイ株式会社 |
光学活性α−トコトリエノールの製造方法
|
|
JPH029875A
(ja)
|
1988-03-16 |
1990-01-12 |
Bio Ind Kyokai |
トコフェロール及びトコトリエノールの製造方法
|
|
US5157132A
(en)
*
|
1990-05-18 |
1992-10-20 |
Carotech Associates |
Integrated process for recovery of carotenoids and tocotrienols from oil
|
|
SG48108A1
(en)
|
1991-11-22 |
1998-04-17 |
Lipogenenics Inc |
Tocotrienols and tocotrienol-like compounds and methods for their use
|
|
DK0735033T3
(da)
*
|
1995-03-28 |
2000-10-23 |
Hoffmann La Roche |
Aminomethylering af tocopheroler
|
|
US5660691A
(en)
|
1995-11-13 |
1997-08-26 |
Eastman Chemical Company |
Process for the production of tocotrienol/tocopherol blend concentrates
|
|
US6232060B1
(en)
|
1996-01-19 |
2001-05-15 |
Galileo Laboratories, Inc. |
Assay system for anti-stress agents
|
|
US5801159A
(en)
|
1996-02-23 |
1998-09-01 |
Galileo Laboratories, Inc. |
Method and composition for inhibiting cellular irreversible changes due to stress
|
|
US5932748A
(en)
|
1997-06-06 |
1999-08-03 |
Roche Vitamins Inc. |
Process for permethylating non-α-tocopherols to produce α-tocopherol
|
|
CN1137077C
(zh)
*
|
1997-10-29 |
2004-02-04 |
弗莱克斯塞思美国有限合伙公司 |
使用过氧化氢和催化剂由苯二胺制备醌二亚胺的方法
|
|
EP1051412B1
(en)
|
1998-01-29 |
2003-09-24 |
Eastman Chemical Company |
Methods for separating a tocotrienol from a tocol-containing mixture and compositions thereof
|
|
MY125803A
(en)
*
|
1998-11-06 |
2006-08-30 |
Fuji Chem Ind Co Ltd |
A tocotrienol-containing powder, a process for preparing it and a tablet comprising compressed said powder into a tablet form
|
|
US6395915B1
(en)
|
1999-09-10 |
2002-05-28 |
Technikrom, Inc. |
Method for producing purified tocotrienols and tocopherols using liquid chromatography
|
|
MY127451A
(en)
|
1999-11-04 |
2006-12-29 |
Malaysian Palm Oil Board |
A method of chromatographic isolation for vitamin e isomers
|
|
DE10034233A1
(de)
*
|
2000-07-14 |
2002-01-24 |
Basf Ag |
Tocotrienolchinon-Cyclisierungsprodukte
|
|
US7034054B2
(en)
|
2000-12-15 |
2006-04-25 |
Galileo Pharmaceuticals, Inc. |
Methods for the prevention and treatment of cerebral ischemia using non-alpha tocopherols
|
|
US6838104B2
(en)
|
2000-12-20 |
2005-01-04 |
Archer Daniels Midland Company |
Process for the production of tocotrienols
|
|
US6608196B2
(en)
|
2001-05-03 |
2003-08-19 |
Galileo Pharmaceuticals, Inc. |
Process for solid supported synthesis of pyruvate-derived compounds
|
|
JP4842455B2
(ja)
|
2001-06-13 |
2011-12-21 |
コマツＮｔｃ株式会社 |
半導体単結晶引上げ装置及びそのライン構成
|
|
JP2003171376A
(ja)
|
2001-09-27 |
2003-06-20 |
Lion Corp |
トコフェロール類及びトコトリエノール類濃縮物、その製造方法
|
|
US6667330B2
(en)
|
2002-01-31 |
2003-12-23 |
Galileo Pharmaceuticals, Inc. |
Furanone derivatives
|
|
US6653346B1
(en)
|
2002-02-07 |
2003-11-25 |
Galileo Pharmaceuticals, Inc. |
Cytoprotective benzofuran derivatives
|
|
US6590113B1
(en)
|
2002-03-26 |
2003-07-08 |
Ronald T. Sleeter |
Process for treating oils containing antioxidant compounds
|
|
AU2003287250B9
(en)
|
2002-10-30 |
2010-01-28 |
Ptc Therapeutics, Inc. |
Identifying therapeutic compounds based on their physical-chemical properties
|
|
MY130618A
(en)
|
2002-11-27 |
2007-07-31 |
Malaysian Palm Oil Board |
A method of extracting and isolating minor components from vegetable oil
|
|
WO2005033093A1
(en)
|
2003-09-19 |
2005-04-14 |
Galileo Pharmaceuticals, Inc. |
7,8-bicycloalkyl-chroman derivatives
|
|
WO2005035490A2
(en)
|
2003-10-10 |
2005-04-21 |
Yasoo Health, Inc. |
PROCESS FOR SYNTHESIZING d-TOCOTRIENOLS
|
|
MY173044A
(en)
|
2003-11-19 |
2019-12-20 |
Carotech Bhd |
Recovery of phytonutriens from oils
|
|
US7393662B2
(en)
|
2004-09-03 |
2008-07-01 |
Centocor, Inc. |
Human EPO mimetic hinge core mimetibodies, compositions, methods and uses
|
|
ES2619303T3
(es)
*
|
2005-06-01 |
2017-06-26 |
Edison Pharmaceuticals, Inc. |
Productos terapéuticos redox activos para el tratamiento de enfermedades mitocondriales y otras afecciones y modulación de biomarcadores energéticos
|
|
SI1933821T1
(sl)
|
2005-09-15 |
2020-11-30 |
Ptc Therapeutics, Inc. |
Repne variante redoks-aktivnih terapevtikov za zdravljenje mitohondrijskih bolezni in drugih bolezni ter modulacijo energijskih biooznačevalcev
|
|
WO2007100652A2
(en)
|
2006-02-22 |
2007-09-07 |
Edison Pharmaceuticals, Inc. |
Side chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
|
|
WO2007105297A1
(ja)
*
|
2006-03-13 |
2007-09-20 |
Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo |
メチン系色素とその用途
|
|
WO2008086025A2
(en)
|
2007-01-10 |
2008-07-17 |
Edison Pharmaceuticals, Inc. |
Treatment of respiratory chain disorders using compounds having erythropoietin or thrombopoietin activity
|
|
WO2008142433A1
(en)
|
2007-05-24 |
2008-11-27 |
Loders Croklaan B.V. |
Process for producing compositions comprising tocoherols and tocotrienols
|
|
EA038941B1
(ru)
|
2007-11-06 |
2021-11-12 |
ПиТиСи ТЕРАПЬЮТИКС, ИНК. |
ПРОИЗВОДНЫЕ 4-(п-ХИНОНИЛ)-2-ГИДРОКСИБУТАНАМИДА ДЛЯ ЛЕЧЕНИЯ МИТОХОНДРИАЛЬНЫХ ЗАБОЛЕВАНИЙ
|
|
EP2242506A4
(en)
|
2008-01-07 |
2011-12-28 |
Janssen Biotech Inc |
METHOD FOR THE TREATMENT OF ERYTHROPOIETIN HYPORESPONSE ANIMALS
|
|
US8952071B2
(en)
|
2008-01-08 |
2015-02-10 |
Edison Pharmaceuticals, Inc. |
(Het)aryl-p-quinone derivatives for treatment of mitochondrial diseases
|
|
WO2009111576A2
(en)
|
2008-03-05 |
2009-09-11 |
Edison Pharmaceuticals, Inc. |
2-SUBSTITUTED-p-QUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES
|
|
EP2262519A4
(en)
*
|
2008-03-05 |
2011-03-23 |
Edison Pharmaceuticals Inc |
TREATMENT OF HEARING AND BALANCING DISORDERS WITH REDOXACTIVE THERAPEUTICS
|
|
US20110142834A1
(en)
|
2008-05-15 |
2011-06-16 |
Edison Pharmaceuticals, Inc. |
Treatment of hearing and balance impairments using compounds having erythropoietin activity
|
|
US20090291092A1
(en)
|
2008-05-22 |
2009-11-26 |
Miller Guy M |
Treatment of mitochondrial diseases with an erythropoietin mimetic
|
|
JP5798481B2
(ja)
|
2008-06-25 |
2015-10-21 |
エジソン ファーマシューティカルズ， インコーポレイテッド |
酸化ストレス疾患を治療するための２−ヘテロシクリルアミノアルキル−（ｐ−キノン）誘導体
|
|
WO2010005989A1
(en)
|
2008-07-09 |
2010-01-14 |
Edison Pharmaceuticals, Inc. |
Dermatological compositions with anti-aging and skin even-toning properties
|
|
US20100029784A1
(en)
|
2008-07-30 |
2010-02-04 |
Hinman Andrew W |
Naphthoquinone compositions with anti-aging, anti-inflammatory and skin even-toning properties
|
|
WO2010014758A1
(en)
|
2008-07-30 |
2010-02-04 |
Edison Pharmaceuticals, Inc. |
Use of hydrogenated pyrido[4,3-b] indoles for the treatment of oxidative stress
|
|
MX363223B
(es)
|
2008-09-10 |
2019-03-15 |
Bioelectron Tech Corp |
Tratamiento de trastornos generalizados del desarrollo con terapeuticos con actividad redox.
|
|
EP2362726B1
(en)
|
2008-10-14 |
2018-08-08 |
Bioelectron Technology Corporation |
Treatment of oxidative stress disorders including contrast nephropathy, radiation damage and disruptions in the function of red cells
|
|
ES2553557T3
(es)
*
|
2008-10-28 |
2015-12-10 |
Edison Pharmaceuticals, Inc. |
Proceso para la producción de alfa-tocotrienol y derivados
|
|
US20120136048A1
(en)
|
2009-04-28 |
2012-05-31 |
Miller Guy M |
Topical, periocular, or intraocular use of tocotrienols for the treatment of ophthalmic diseases
|
|
CA2777479C
(en)
|
2009-04-28 |
2017-10-17 |
Ptc Therapeutics, Inc. |
Treatment of leber's hereditary optic neuropathy and dominant optic atrophy with tocotrienol quinones
|
|
EA201101576A1
(ru)
|
2009-04-28 |
2012-04-30 |
Эдисон Фармасьютикалз, Инк. |
Лекарственная форма токотриенол хинонов для лечения офтальмических (глазных) заболеваний
|
|
EP2445519A4
(en)
|
2009-06-25 |
2012-12-26 |
Ampere Life Sciences Inc |
TREATMENT OF PERVASIVE DEVELOPMENT DISORDERS USING TOCOTRIENOLS OR TOCOTRIENOLS ENRICHED EXTRACTS
|
|
NO2470168T3
(https=)
|
2009-08-26 |
2018-06-30 |
|
|
|
US20110172312A1
(en)
|
2009-12-31 |
2011-07-14 |
Miller Guy M |
Treatment of leigh syndrome and leigh-like syndrome with tocotrienol quinones
|
|
BR112012022634A2
(pt)
|
2010-03-09 |
2019-09-24 |
Edison Pharmaceuticals Inc |
síntese de derivados de alto-tocoferolquinona e métodos de utilização dos mesmos
|
|
WO2011113018A1
(en)
|
2010-03-12 |
2011-09-15 |
Ampere Life Sciences, Inc. |
Measurement and control of biological time
|
|
CA2795726A1
(en)
|
2010-04-06 |
2011-10-13 |
Edison Pharmaceuticals, Inc. |
Treatment of ataxia telangiectasia
|
|
JP5902673B2
(ja)
|
2010-04-27 |
2016-04-13 |
エジソン ファーマシューティカルズ， インコーポレイテッド |
眼疾患の処置のためのキノンの製剤
|
|
US20120101169A1
(en)
|
2010-07-14 |
2012-04-26 |
Penwest Pharmaceuticals Co. |
Methods of providing anticoagulation effects in subjects
|
|
SG187744A1
(en)
|
2010-08-06 |
2013-03-28 |
Edison Pharmaceuticals Inc |
Treatment of mitochondrial diseases with naphthoquinones
|
|
US20120295985A1
(en)
|
2010-11-19 |
2012-11-22 |
Miller Guy M |
Methods for improving blood glucose control
|
|
WO2012154613A1
(en)
|
2011-05-06 |
2012-11-15 |
Edison Pharmaceuticals, Inc. |
Improved process for the preparation of d-alpha-tocotrienol from natural extracts
|
|
WO2012170773A1
(en)
|
2011-06-08 |
2012-12-13 |
Edison Pharmaceuticals, Inc. |
Adjunctive therapy for the treatment of mitochondrial disorders with quinones and naphthoquinones
|
|
WO2012174286A1
(en)
|
2011-06-14 |
2012-12-20 |
Edison Pharmaceuticals, Inc. |
Catechol derivatives for treatment of oxidative stress diseases
|
|
WO2013006736A1
(en)
|
2011-07-06 |
2013-01-10 |
Edison Pharmaceuticals, Inc |
Treatment of leigh syndrome and leigh-like syndrome, including complications of sucla2 mutations, with tocotrienol quinones
|
|
ES2795798T3
(es)
|
2011-07-06 |
2020-11-24 |
Ptc Therapeutics Inc |
Tratamiento de aciduria metilmalónica, aciduria isovalérica, y otras acidurias orgánicas con tocotrienol quinonas
|
|
EP2734512B1
(en)
|
2011-07-19 |
2019-11-20 |
Bioelectron Technology Corporation |
Methods for selective oxidation of alpha tocotrienol in the presence of non-alpha tocotrienols
|
|
CA2883882A1
(en)
|
2012-09-07 |
2014-03-13 |
Ptc Therapeutics, Inc. |
Benzoquinone derivatives for treating oxidative stress disorders
|
|
US8937191B2
(en)
|
2012-12-20 |
2015-01-20 |
Orochem Technologies, Inc. |
Recovery of highly pure alpha-tocotrienol from crude palm oil extract
|
|
CN105142603B
(zh)
|
2013-03-08 |
2018-10-19 |
荷兰联合利华有限公司 |
用于皮肤病用途的间苯二酚化合物
|
|
US9868711B2
(en)
|
2013-03-15 |
2018-01-16 |
Bioelectron Technology Corporation |
Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders
|
|
US20140275045A1
(en)
|
2013-03-15 |
2014-09-18 |
Edison Pharmaceuticals, Inc. |
Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders
|
|
US9670170B2
(en)
|
2013-03-15 |
2017-06-06 |
Bioelectron Technology Corporation |
Resorufin derivatives for treatment of oxidative stress disorders
|
|
US9296712B2
(en)
|
2013-03-15 |
2016-03-29 |
Edison Pharmaceuticals, Inc. |
Resorufin derivatives for treatment of oxidative stress disorders
|
|
US10189830B2
(en)
|
2013-03-15 |
2019-01-29 |
Bioelectron Technology Corporation |
Alkyl-heteroaryl substituted quinone derivatives for treatment of oxidative stress disorders
|
|
EP3004071A1
(en)
|
2013-05-31 |
2016-04-13 |
Edison Pharmaceuticals, Inc. |
Carboxylic acid derivatives for treatment of oxidative stress disorders
|
|
EP3233819A1
(en)
|
2014-12-16 |
2017-10-25 |
Bioelectron Technology Corporation |
Methods for chiral resolution of trolox
|
|
DK3233786T3
(da)
|
2014-12-16 |
2022-05-09 |
Ptc Therapeutics Inc |
Polymorfe og amorfe former af (r)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6- dioxocyclohexa-1,4-dienyl)butanamid
|
|
JP2018502127A
(ja)
|
2015-01-12 |
2018-01-25 |
バイオエレクトロン テクノロジー コーポレイション |
放射線被曝に対する防護のためのキノン
|
|
WO2017106786A1
(en)
|
2015-12-16 |
2017-06-22 |
Bioelectron Technology Corporation |
Improved methods for enriching alpha-tocotrienol from mixed tocol compositions
|
|
US10703701B2
(en)
|
2015-12-17 |
2020-07-07 |
Ptc Therapeutics, Inc. |
Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
|
|
CA3011293A1
(en)
|
2016-01-12 |
2017-07-20 |
Ptc Therapeutics, Inc. |
Tocopherol and tocotrienol quinone derivatives for increasing thiosulfate levels or decreasing hydrogen sulfide levels
|
|
WO2017123823A1
(en)
|
2016-01-12 |
2017-07-20 |
Bioelectron Technology Corporation |
Alkyl-, acyl-, urea-, and aza-uracil sulfide:quinone oxidoreductase inhibitors
|
|
WO2018081644A1
(en)
|
2016-10-28 |
2018-05-03 |
Bioelectron Technology Corporation |
Methods of analyzing p-hydroquinone levels and ratios
|
|
WO2018093957A1
(en)
|
2016-11-15 |
2018-05-24 |
Bioelectron Technology Corporation |
2-substituted amino-naphth[1,2-d]imidazol-5-one compounds or pharmaceutically acceptable salts thereof cross reference to related applications
|
|
WO2018129411A1
(en)
|
2017-01-06 |
2018-07-12 |
Bioelectron Technology Corporation |
Aryl- and heteroaryl-resorufin derivatives for treatment of oxidative stress disorders and liver and kidney disorders
|
|
WO2018191732A1
(en)
|
2017-04-14 |
2018-10-18 |
Bioelectron Technology Corporation |
Methods and compositions for treatment of inflammation and oxidative stress
|